AB&B BIO-TECH-B (02627) Selected for Inclusion in Hang Seng Composite Index

Stock News02-16

AB&B BIO-TECH-B (02627) announced that its H-shares have been selected and will be included as a constituent stock of the Hang Seng Composite Index, effective from March 9, 2026. The Hang Seng Composite Index serves as a comprehensive H-share benchmark, covering companies listed on the Main Board of the Hong Kong Exchange that collectively represent the top 95% of cumulative market capitalization. It is widely used by index funds, mutual funds, and performance evaluation systems. The Board of Directors believes that the company's inclusion in the Hang Seng Composite Index reflects capital market recognition of its business performance and growth prospects. The Board is confident that this inclusion will help broaden the company's shareholder base, enhance the trading liquidity of its H-shares, and further strengthen its reputation and brand visibility.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment